Clinical Trial Update: An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

This document reports on an extension Phase 2 study evaluating telbivudine, lamivudine, or their combination in patients with chronic hepatitis B, with the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)
• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED